National Cancer Institute awarding funds nationwide
Fiscal year 2009 drew to a close on Sept. 30, leaving the National Institutes of Health (NIH) with one more year to make decisions and allocate $10.4 billion in short-term funds it received through the American Recovery and Reinvestment Act of 2009 (ARRA).
To date, the National Cancer Institute (NCI) has obligated more than half of the $1.3 billion it received through the stimulus act. According to its website, NCI has awarded a total of $846 million to support research across the country; $521 million of that total will support investigator-initiated research proposals and $318 million will go toward contract awards for specific goods and services that support NCI's research activities.
NCI has also highlighted several specific programs of note that are receiving NCI ARRA funds, including:
- The Cancer Genome Atlas (TCGA): $ 175 million
- Accelerating Clinical Trials of Novel Oncologic PathWays (ACTNOW): $36 million
- Therapeutically Applicable Research to Generate Effective Treatments (TARGET): $25 million
- The Cancer Human Biobank (caHUB): $60 million
- The NCI Community Cancer Centers Program (NCCCP): $80 million
Read more from the October 2009 Edition of the AACR Cancer Policy Monitor: